Table: Zeria Pharm -Q1 group results

Zeria Pharmaceutical

05/08/2025 08:00

Aug 5 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Mar 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             19.49               21.46            90.00    
                 (-9.2 pct)          (+17.2 pct)      (+3.1 pct)  
  Operating          1.52                3.94            12.00    
                 (-61.4 pct)         (+32.6 pct)      (-1.6 pct)  
  Recurring          1.66                5.46            12.00    
                 (-69.6 pct)         (+62.7 pct)      (-6.5 pct)  
  Net                1.09                4.21             9.50    
                 (-74.1 pct)         (+44.5 pct)      (-4.4 pct)  
  EPS             24.75 yen           95.57 yen       215.52 yen  
  Ann Div                             47.00 yen        48.00 yen  
  -Q2 div                             23.00 yen        24.00 yen  
  -Q4 div                             24.00 yen        24.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T